Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
351 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (1)
  • Closed (4)

Medical Condition

  • Show all (182)
  • Autoimmune Disorders (3)
  • Blood Disorders (8)
  • Cancer (111)
    • Bladder Cancer (1)
    • Brain Cancer (2)
    • Breast Cancer (2)
    • Gastrointestinal (3)
    • Gynecologic Cancer (3)
    • (-) Head and Neck Cancer (2)
    • Kidney Cancer (3)
    • Leukemia (9)
    • Liver Cancer (1)
    • Lung Cancer (14)
    • Lymphoma (8)
    • Multiple Myeloma (6)
    • Pancreatic Cancer (1)
    • Prostate Cancer (9)
    • Sarcoma (4)
    • Skin Cancer (5)
    • Solid Tumors (7)
  • Diabetes (1)
  • Healthy Volunteers (3)
  • Heart Disease (2)
  • (-) Infectious Disease (3)
    • HIV (2)
  • Neurological Disorders (16)
  • Nutrition (1)
  • Obstetrics & Gynecology (1)
  • Pediatrics (15)
  • Psychiatric Disorders (1)
  • Transplant (16)
  • Urology (1)
Displaying 1 - 5 of 5

A study for patients with Melanoma, Squamous Cell Cancer of the Head and Neck, or Non-Small Cell Lung cancer using study drug MGA271

Condition: Cancer / Head and Neck Cancer
Investigator: Richard Carvajal, MD
Status: Closed
The study involves research about MGA271 in combination with Keytruda. MGA271 targets cancer cells that make a lot of a protein called B7-H3. Another way to say it is that the cells "overexpress" the protein. Very few normal cells express B7-H3. MGA271 is though to…
Read More

HIV Vaccine: HVTN 807

Condition: Infectious Disease / HIV
Investigator: Magdalena Sobieszczyk, MD
Status: Currently Recruiting
The HIV Vaccine Trials Network (HVTN), Division of AIDS (DAIDS), and Columbia University Irving Medical Center (CUIMC) are conducting a trial to learn about the safety and effectiveness of a new experimental HIV vaccine. The goal is to understand if the study products are safe to use in people living with HIV, and whether they can get the study products…
Read More

Antibodies against HIV

Condition: Infectious Disease / HIV
Investigator: Magdalena Sobieszczyk, MD
Status: Closed
We are testing two antibodies directed against HIV virus. The human body uses antibodies as one way to help fight infection.The antibodies are called VRC01LS and VRC07-523LS and they are given by IV infusion. Each participant will receive one dose by infusion. The main purpose of this study is to see if these two antibodies are safe and how a participants…
Read More

Study of the Hologic Cytomegalovirus (CMV) Assay

Condition: Infectious Disease
Investigator: Marcus Pereira, MD, MPH
Status: Closed
This research study for people who have tested positive for cytomegalovirus (CMV) after receiving a solid-organ transplant or stem cell transplant. This is a non-interventional study. This study involves the use of an investigational test called the Aptima CMV Quantification Diagnostic Assay (…
Read More

Study of ADU-S100 and Pembrolizumab in Head and Neck Cancer

Condition: Cancer / Head and Neck Cancer
Investigator: Matthen Mathew, MD
Status: Closed
The purpose of this study is to study ADU-S100 and pembrolizumab in patients with recurrent or metastatic head and neck squamous cell cancer (HNSCC). This study aims to evaluate how safe and effective this drug combination is at treating your cancer. These drugs are thought to work by interacting with your immune sy…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science